Literature DB >> 7554472

Adenosine deaminase deficiency: molecular basis and recent developments.

R Hirschhorn1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7554472     DOI： 10.1016/s0090-1229(95)90288-0

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN： 0090-1229


× No keyword cloud information.
  14 in total

Review 1.  A(2A) adenosine receptors in human peripheral blood cells.

Authors:  S Gessi; K Varani; S Merighi; E Ongini; P A Borea
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

2.  Macrophages are a source of extracellular adenosine deaminase-2 during inflammatory responses.

Authors:  B A Conlon; W R Law
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

3.  Therapeutic benefit of pentostatin in severe IL-10-/- colitis.

Authors:  Jeffrey B Brown; Goo Lee; Gery R Grimm; Terrence A Barrett
Journal:  Inflamm Bowel Dis       Date:  2008-07       Impact factor: 5.325

4.  Insights into thymic purine metabolism and adenosine deaminase deficiency revealed by transgenic mice overexpressing ecto-5'-nucleotidase (CD73).

Authors:  R Resta; S W Hooker; A B Laurent; S M Jamshedur Rahman; M Franklin; T B Knudsen; N L Nadon; L F Thompson
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

Review 5.  Erythrocyte-mediated delivery of recombinant enzymes.

Authors:  Vincenzo Leuzzi; Luigia Rossi; Claudia Gabucci; Francesca Nardecchia; Mauro Magnani
Journal:  J Inherit Metab Dis       Date:  2016-03-30       Impact factor: 4.982

6.  High-efficiency gene transfer into normal and adenosine deaminase-deficient T lymphocytes is mediated by transduction on recombinant fibronectin fragments.

Authors:  K E Pollok; H Hanenberg; T W Noblitt; W L Schroeder; I Kato; D Emanuel; D A Williams
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

Review 7.  Clinical expression, genetics and therapy of adenosine deaminase (ADA) deficiency.

Authors:  M S Hershfield; F X Arredondo-Vega; I Santisteban
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

8.  Study of A(2A) adenosine receptor gene deficient mice reveals that adenosine analogue CGS 21680 possesses no A(2A) receptor-unrelated lymphotoxicity.

Authors:  S G Apasov; J F Chen; P T Smith; M A Schwarzschild; J S Fink; M V Sitkovsky
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

9.  Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency.

Authors:  Donald B Kohn; Claire Booth; Kit L Shaw; Jinhua Xu-Bayford; Elizabeth Garabedian; Valentina Trevisan; Denise A Carbonaro-Sarracino; Kajal Soni; Dayna Terrazas; Katie Snell; Alan Ikeda; Diego Leon-Rico; Theodore B Moore; Karen F Buckland; Ami J Shah; Kimberly C Gilmour; Satiro De Oliveira; Christine Rivat; Gay M Crooks; Natalia Izotova; John Tse; Stuart Adams; Sally Shupien; Hilory Ricketts; Alejandra Davila; Chilenwa Uzowuru; Amalia Icreverzi; Provaboti Barman; Beatriz Campo Fernandez; Roger P Hollis; Maritess Coronel; Allen Yu; Krista M Chun; Christian E Casas; Ruixue Zhang; Serena Arduini; Frances Lynn; Mahesh Kudari; Andrea Spezzi; Marco Zahn; Rene Heimke; Ivan Labik; Roberta Parrott; Rebecca H Buckley; Lilith Reeves; Kenneth Cornetta; Robert Sokolic; Michael Hershfield; Manfred Schmidt; Fabio Candotti; Harry L Malech; Adrian J Thrasher; H Bobby Gaspar
Journal:  N Engl J Med       Date:  2021-05-11       Impact factor: 91.245

Review 10.  Advances in the understanding and treatment of human severe combined immunodeficiency.

Authors:  R H Buckley
Journal:  Immunol Res       Date:  2000       Impact factor: 4.505
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.